Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has dosed its first patient in the ...

Ovarian cancer is a disease where abnormal cells grow in or around the ovaries, the organs responsible for producing eggs and ...

Ovarian cancer remains a significant global health challenge, often diagnosed at an advanced stage due to non-specific ...

Test, developed by University of Cambridge, looks at structure of tumour DNA and forecasts whether it will resist treatment ...

Tens of thousands of cancer patients going through gruelling chemotherapy could have DNA test to predict which form of the ...

Seoul National University Hospital recently announced that it successfully performed the first high-level ovarian cancer ...

Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer ...

There may be hopeful news ahead for families with a history of breast and ovarian cancer. Researchers from the University of ...

CAR-T therapy targeting TM4SF1 in aggressive bladder cancer (HV) histologic variant , offering hope for treatment-resistant ...

A model with eight independent risk factors can predict the risk for deep vein thrombosis in patients with epithelial ovarian cancer.

As the planet heats up, a silent and dangerous health crisis is emerging in the Middle East and North Africa. Published in ...